| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |